Stevanato Group SpA
NYSE:STVN

Watchlist Manager
Stevanato Group SpA Logo
Stevanato Group SpA
NYSE:STVN
Watchlist
Price: 21 USD -0.1%
Market Cap: 6.3B USD
Have any thoughts about
Stevanato Group SpA?
Write Note

Stevanato Group SpA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stevanato Group SpA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Stevanato Group SpA
NYSE:STVN
EPS (Diluted)
€0
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
EPS (Diluted)
€0
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stevanato Group SpA
Glance View

Market Cap
6.3B USD
Industry
Life Sciences Tools & Services

Stevanato Group SpA, a stalwart in the realm of pharmaceutical and healthcare solutions, has carved its niche as a pioneering force in precision glass packaging and integrated drug delivery systems. founded in 1949 in Italy, the company ingeniously combines its deep-rooted expertise in glass manufacturing with cutting-edge technology to meet the burgeoning demands of the healthcare and pharmaceutical sectors. Stevanato’s operations are deftly structured around two main segments: the pharmaceutical systems division and the engineering division. Through its pharmaceutical systems division, the company crafts highly specialized glass vials, syringes, and cartridges critical for ensuring the safety and efficacy of drug delivery. These glass containers are not mere vessels but are integral to preserving the integrity of high-value biologic drugs, a prerequisite for gaining regulatory approval and market success. Reaping the benefits of a vertically integrated business model, Stevanato’s engineering division complements its offerings by designing, developing, and manufacturing machinery and technology that optimize the production and inspection of its glass products. This segment caters to pharmaceutical companies' needs for enhanced reliability and efficiency in manufacturing processes, enabling Stevanato to cover the entire value chain from raw material sourcing to final packaging inspection. This seamless integration not only fortifies the company's market position but also ensures a robust revenue stream from both products and services. Stevanato Group's commitment to innovation and quality control, coupled with strategic collaborations, have propelled it as an indispensable partner to global pharmaceutical giants, anchoring its role as both a defender of drug integrity and a trailblazer in medical glassware innovation.

STVN Intrinsic Value
17.78 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Stevanato Group SpA's EPS (Diluted)?
EPS (Diluted)
0.6 EUR

Based on the financial report for Dec 31, 2023, Stevanato Group SpA's EPS (Diluted) amounts to 0.6 EUR.

What is Stevanato Group SpA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
27%

Over the last year, the EPS (Diluted) growth was 2%. The average annual EPS (Diluted) growth rates for Stevanato Group SpA have been 27% over the past three years .

Back to Top